1212
M. Barbasiewicz et al.
PAPER
MS (ESI): m/z [M + Na]+ calcd for C18H20NaO4S: 355.1; found:
MS (ESI): m/z [M + Na]+ calcd for C13H16NaO3: 243.1; found:
355.1.
243.1.
Anal. Calcd for C18H20O4S: C, 65.04; H, 6.06; S, 9.65. Found: C,
64.93; H, 6.08; S, 9.44.
Anal. Calcd for C13H16O3: C, 70.89; H, 7.32. Found: C, 70.58; H,
7.22.
2-(4-Chlorophenyl)-3-(phenylsulfonyl)tetrahydro-2H-pyran
(3c)
Methyl 2-(4-Bromophenyl)tetrahydro-2H-pyran-3-carboxy-
late (3g)
Mp 123–124 °C.
Oil.
IR (KBr): 2921, 2865, 1600, 1494, 1446, 1306, 1285, 1143, 1089,
1025, 952, 817, 745, 721, 682, 606, 552, 526 cm–1.
IR (neat): 2950, 2851, 1734, 1593, 1490, 1435, 1365, 1317, 1258,
1162, 1096, 1012, 956, 815, 539 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.40–7.59 (m, 3 H), 7.28–7.39 (m,
2 H), 7.07–7.20 (m, 4 H), 4.60 (d, J = 9.6 Hz, 1 H), 4.07–4.18 (m, 1
H), 3.44–3.73 (m, 2 H), 2.52–2.66 (m, 1 H), 2.13 (dd, J = 12.7, 4.8
Hz, 1 H), 1.77–2.06 (m, 2 H).
1H NMR (200 MHz, CDCl3): d = 7.45–7.53 (m, 2 H), 7.16–7.24 (m,
2 H), 4.41 (d, J = 10.1 Hz, 1 H), 4.06–4.17 (m, 1 H), 3.54–3.69 (m,
1 H), 3.46 (s, 3 H), 2.53–2.67 (m, 1 H), 2.08–2.21 (m, 1 H), 1.64–
2.00 (m, 3 H).
13C NMR (50 MHz, CDCl3): d = 139.1, 136.3, 134.5, 132.7, 129.6,
128.6, 128.4, 127.8, 79.9, 68.3, 65.0, 25.4, 23.7.
13C NMR (50 MHz, CDCl3): d = 173.5, 139.4, 131.4, 128.6, 121.9,
80.6, 68.5, 51.5, 49.7, 27.7, 24.6.
MS (ESI): m/z [M(35Cl) + Na]+ calcd for C17H1735ClNaO3S: 359.0;
MS (EI): m/z (%) = 300 (30), 298 (31), 240 (58), 238 (60), 185 (50),
found: 359.0.
183 (50), 114 (100).
Anal. Calcd for C17H17ClO3S: C, 60.62; H, 5.09; Cl, 10.53; S, 9.52.
Found: C, 60.66; H, 5.09; Cl, 9.92; S, 9.81.
Anal. Calcd for C13H15BrO3: C, 52.19; H, 5.05; Br, 26.71. Found:
C, 52.05; H, 5.31; Br, 26.86.
2-(2-Furyl)-3-(phenylsulfonyl)tetrahydro-2H-pyran (3d)
Mp 126–128 °C.
3-Benzoyl-2-phenyltetrahydro-2H-pyran (3h)
To a stirred soln of 1d (241 mg, 1 mmol) and benzaldehyde (265
mg, 2.5 mmol) in EtOH (3 mL) at r.t. under argon was added a soln
of t-BuOK (238 mg, 2.1 mmol) in EtOH (2 mL). The mixture was
left overnight, then aq NH4Cl was added with vigorous stirring and
the product 3h was isolated according to the typical procedure; mp
76–80 °C.
IR (KBr): 3145, 2971, 2882, 1585, 1503, 1448, 1346, 1305, 1284,
1142, 1075, 1025, 941, 919, 878, 850, 817, 758, 749, 721, 687, 605,
550 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.33–7.63 (m, 5 H), 6.93 (d,
J = 1.9 Hz, 1 H), 6.29 (dd, J = 3.3, 0.6 Hz, 1 H), 6.11 (dd, J = 3.3,
1.9 Hz, 1 H), 4.64 (d, J = 9.7 Hz, 1 H), 3.96–4.08 (m, 1 H), 3.67–
3.82 (m, 1 H), 3.46–3.61 (m, 1 H), 2.43–2.58 (m, 1 H), 1.67–2.13
(m, 3 H).
IR (KBr): 3062, 3033, 2947, 2850, 1674, 1596, 1449, 1365, 1299,
1260, 1197, 1088, 1033, 952, 928, 831, 756, 699, 665, 551 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.62–7.72 (m, 2 H), 7.06–7.50 (m,
8 H), 4.71 (d, J = 9.7 Hz, 1 H), 4.14–4.26 (m, 1 H), 3.65–3.81 (m, 2
H), 1.67–2.22 (m, 4 H).
13C NMR (50 MHz, CDCl3): d = 202.1, 140.6, 136.6, 132.9, 128.4,
128.2, 127.9, 127.8, 126.9, 81.8, 68.5, 50.8, 28.7, 25.2.
13C NMR (50 MHz, CDCl3): d = 149.8, 142.8, 138.5, 132.9, 128.8,
128.1, 110.3, 71.9, 67.9, 62.1, 24.8, 23.2.
MS (EI): m/z (%) = 292 (1), 169 (2), 150 (100), 125 (22), 122 (19).
Anal. Calcd for C15H16O4S: C, 61.63; H, 5.52; S, 10.97. Found: C,
61.37; H, 5.66; S, 11.26.
MS (EI): m/z (%) = 266 (37), 160 (66), 146 (23), 131 (7), 117 (5),
115 (4), 105 (100), 91 (8), 77 (42).
2-tert-Butyl-3-(phenylsulfonyl)tetrahydro-2H-pyran (3e)
Oil.
Anal. Calcd for C18H18O2: C, 81.17; H, 6.81. Found: C, 80.86; H,
6.75.
IR (neat): 2961, 2878, 1585, 1478, 1445, 1299, 1282, 1212, 1144,
1079, 930, 763, 738, 688, 589, 445 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.86–7.95 (m, 2 H), 7.52–7.71 (m,
3 H), 3.67–3.99 (m, 2 H), 3.83 (d, J = 3.3 Hz, 1 H), 3.16–3.24 (m, 1
H), 1.65–2.04 (m, 4 H), 0.86 (s, 9 H).
13C NMR (50 MHz, CDCl3): d = 138.6, 133.7, 129.2, 128.7, 78.7,
62.5, 60.5, 35.8, 25.6, 18.6, 17.9.
1-[4-Bromo-1-(phenylsulfonyl)butyl]cyclohexan-1-ol (2i)
To a stirred soln of 1b (277 mg, 1 mmol) in THF (2 mL) at –75 °C
under argon, 2.0 M LDA in THF–heptane–ethylbenzene (0.5 mL,
Fluka) was added dropwise. After 1 min, a soln of cyclohexanone
(122 mg, 1.25 mmol) in THF (2 mL) was added dropwise and the
mixture was kept at –70 °C for 1 h. Then the flask was warmed to
0 °C (~10 min), aq NH4Cl was added with vigorous stirring and the
product 2i was isolated as an oil according to the typical procedure.
MS (ESI): m/z [M + Na]+ calcd for C15H22NaO3S: 305.1; found:
305.1.
IR (neat): 3516, 3063, 2922, 2858, 1585, 1447, 1286, 1137, 1082,
973, 854, 729, 690, 652, 576 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.85–7.98 (m, 2 H), 7.50–7.72 (m,
3 H), 3.80 (s br, 1 H), 3.12 (t, J = 6.3 Hz, 2 H), 3.04 (t, J = 4.5 Hz,
1 H), 1.07–2.17 (m, 14 H).
13C NMR (50 MHz, CDCl3): d = 140.2, 133.8, 129.3, 128.2, 75.1,
73.2, 36.3, 33.7, 32.4, 32.3, 25.3, 25.2, 21.3.
Anal. Calcd for C15H22O3S: C, 63.80; H, 7.85; S, 11.35. Found: C,
63.95; H, 8.06; S, 11.25.
Methyl 2-Phenyltetrahydro-2H-pyran-3-carboxylate (3f)
Oil.
IR (neat): 2950, 2852, 1733, 1495, 1454, 1436, 1368, 1317, 1261,
1162, 1094, 1028, 954, 759, 699, 537 cm–1.
1H NMR (200 MHz, CDCl3): d = 7.28–7.45 (m, 5 H), 4.52 (d,
J = 10.1 Hz, 1 H), 4.15–4.26 (m, 1 H), 3.65–3.79 (m, 1 H), 3.51 (s,
3 H), 2.69–2.84 (m, 1 H), 2.16–2.30 (m, 1 H), 1.8–2.16 (m, 3 H).
13C NMR (50 MHz, CDCl3): d = 173.6, 140.2, 128.3, 128.0, 126.8,
81.4, 68.5, 51.3, 49.7, 27.7, 24.7.
MS (EI): m/z (%) = 376 (1), 374 (1), 278 (24), 276 (23), 235 (76),
233 (79), 217 (50), 215 (51), 197 (11), 169 (64), 165 (18), 163 (19),
137 (30), 135 (32), 99 (100).
HRMS (EI): m/z [M(79Br)]+ calcd for C16H2379BrO3S: 374.05513;
found: 374.05434.
Synthesis 2007, No. 8, 1209–1213 © Thieme Stuttgart · New York